Solvias

Solvias company information, Employees & Contact Information

Explore related pages

Related company profiles:

Solvias helps innovative companies advance their path to commercialization with CMC analytical solutions powered by deep scientific expertise and a relentless focus on our customers’ success. With years of expertise in small molecules, biologics and cell and gene therapies, our talented subject matter experts have the know-how, creativity, and tenacity to solve even the most complex analytical challenges. Solvias offers comprehensive testing solutions from raw materials to final release testing as well as API development for small molecules. Customers have a single, trusted analytical partner for their entire development journey. Our six global facilities are strategically placed in biopharmaceutical hubs. We are GMP, GLP and ISO certified and conduct over 100 successful customer audits every year. We take pride in putting science and quality at the heart of everything we do, helping our customers bring better and safer products to market faster.

Company Details

Employees
644
Founded
-
Address
Römerpark 2, Kaiseraugst,aargau 4303,switzerland
Phone
41 61 845 60 00
Email
in****@****ias.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Kaiseraugst, Aargau
Looking for a particular Solvias employee's phone or email?

Solvias Questions

News

Solvias Opens Center of Excellence for Biologics and Cell & Gene Therapy in Research Triangle Park - PR Newswire

Solvias Opens Center of Excellence for Biologics and Cell & Gene Therapy in Research Triangle Park PR Newswire

Solvias - Contract Pharma

Solvias Contract Pharma

Jarlath Keating Joins as President of Solvias Group USA to Drive Growth and Innovation in Advanced Analytical Services - Lelezard

Jarlath Keating Joins as President of Solvias Group USA to Drive Growth and Innovation in Advanced Analytical Services Lelezard

Solvias to Speak at Festival of Biologics 2025 on Building Robust CMC Assays for Biologic Therapies - The AI Journal

Solvias to Speak at Festival of Biologics 2025 on Building Robust CMC Assays for Biologic Therapies The AI Journal

Videobite: Contract Pharma Sits Down with Steve Smith of Solvias - Contract Pharma

Videobite: Contract Pharma Sits Down with Steve Smith of Solvias Contract Pharma

Solvias to Present at Cell & Gene Therapy International 2025 on Multilayered Quality Control in CGT Manufacturing - Lelezard

Solvias to Present at Cell & Gene Therapy International 2025 on Multilayered Quality Control in CGT Manufacturing Lelezard

Pharmaceutical Technology Excellence Awards 2022: Solvias - Pharmaceutical Technology

Pharmaceutical Technology Excellence Awards 2022: Solvias Pharmaceutical Technology

Solvias to Perform Release Testing on World’s First CRISPR-based Gene-Editing Therapy - BioSpace

Solvias to Perform Release Testing on World’s First CRISPR-based Gene-Editing Therapy BioSpace

Solvias Expands U.S. Capabilities as RTP Center Becomes cGMP-Ready - PR Newswire

Solvias Expands U.S. Capabilities as RTP Center Becomes cGMP-Ready PR Newswire

Reliable particle sizing in vaccine formulations using advanced dynamic light scattering - Frontiers

Reliable particle sizing in vaccine formulations using advanced dynamic light scattering Frontiers

Exploring the Cocrystal Landscape of Posaconazole by Combining High-Throughput Screening Experimentation with Computational Chemistry | Crystal Growth & Design - ACS Publications

Exploring the Cocrystal Landscape of Posaconazole by Combining High-Throughput Screening Experimentation with Computational Chemistry | Crystal Growth & Design ACS Publications

Solvias redefines Asian engagement with focus on analytical services - South China Morning Post

Solvias redefines Asian engagement with focus on analytical services South China Morning Post

Enhancing the Asymmetric Hydrogenation/Desymmetrization of an Achiral Lactone in the Synthesis of (+)-Biotin - ACS Publications

Enhancing the Asymmetric Hydrogenation/Desymmetrization of an Achiral Lactone in the Synthesis of (+)-Biotin ACS Publications

What Will Define the Future of Pharma? Five Trends on Solvias' Radar Ahead of CPHI Frankfurt 2025 - PR Newswire

What Will Define the Future of Pharma? Five Trends on Solvias' Radar Ahead of CPHI Frankfurt 2025 PR Newswire

Solvias Acquires Cergentis to Bolster Biologics and Cell & Gene Therapy Capabilities - PR Newswire

Solvias Acquires Cergentis to Bolster Biologics and Cell & Gene Therapy Capabilities PR Newswire

Solvias Appoints Archie Cullen Chief Executive Officer - PR Newswire

Solvias Appoints Archie Cullen Chief Executive Officer PR Newswire

Solvias Acquires Chemic Laboratories to Establish U.S. Laboratory Presence and Expand Testing Services - PR Newswire

Solvias Acquires Chemic Laboratories to Establish U.S. Laboratory Presence and Expand Testing Services PR Newswire

Water Street Healthcare Partners acquires pharma company Solvias - Private Equity Wire

Water Street Healthcare Partners acquires pharma company Solvias Private Equity Wire

Chiral Mixed Secondary Phosphine‐Oxide–Phosphines: High‐Performing and Easily Accessible Ligands for Asymmetric Hydrogenation - Landert - 2010 - Angewandte Chemie International Edition - Wiley Online Library

Chiral Mixed Secondary Phosphine‐Oxide–Phosphines: High‐Performing and Easily Accessible Ligands for Asymmetric Hydrogenation - Landert - 2010 - Angewandte Chemie International Edition Wiley Online Library

Top Solvias Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant